Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewGENESIS Tech Transfer Boost incorporates a new investment partner, PINONO S.L.
GENESIS Tech Transfer Boost is an investment vehicle created in 2022 that invests in the field of Biomedicine.
-
EventISCT 2024
-
NewORYZON to provide corporate progress updates at several events in February-March
Keystone Symposia Epigenetic Mechanisms and Cancer Treatment; Bio-Neuroscience; 17º Annual European Life Sciences CEO Forum and BIO-Europe Spring 2024.
-
CompanyMATCH BIOSYSTEMS
-
Press releaseBiotechnology is revolutionizing the present and future of the fight against cancer
Immunotherapy, gene therapy, the study of mRNA and its potential application in vaccines, nanotechnology, liquid biopsy, the development of specific biomarkers, and CAR-T cells are just a few examples
-
NewDrug Discovery, Early Diagnosis, and New Treatments: This is how biotechnology has changed...
On World Cancer Day, we take a look at the role that biotechnology has played in recent years in crucial areas related to cancer.
-
NewGENESIS Tech Transfer Boost invests €50,000 in the start-up Affirma Biotech
Affirma Biotech develops immune system activation compounds for the treatment of infectious diseases.
-
New3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pan-European...
Through this combination, the Group will become one of the main independent European bio-CDMOs, with gross sales above €75m.
-
New#NewAseBioMember | “AseBio is a meeting place for companies in the bio sector, which can a...
Meet Afarvi Sistemas, our new member. We talked to its Juan Antonio de la Cuerda Pérez, responsable de Desarrollo de Negocio y Marketing.
-
CompanySavana
-
-
-
NewBIOLAN continues its commitment to certification and international recognition of its bios...
This latest recognition is of vital importance for BIOLAN, which sees how the technological advances of its products (3000 and 7000 series) continue to maintain a high level of quality and usefulness
-
-
NewAseBio values positively the vote on NGTs, but the proposal to ban patents could hinder in...
The total ban on patents for all plants obtained through the use of NGTs, claiming to avoid "legal uncertainties, higher costs, and new dependencies for farmers and breeders," will discourage
-
Press release
AseBio values positively the vote on NGTs, but the proposal to ban patents could hinder in...
Members of the European Parliament have agreed with the proposal to have two different categories and two sets of rules for plants derived from the use of NGTs. The total ban on patents for all plants
-
NewHistocell obtains AEMPS authorisation and GMP certification for its new manufacturing plan...
The biopharmaceutical company reaffirms its commit.
-
New#NewAllyAseBio | "Asebio is a benchmark in the sector that fosters and promotes alliances ...
Meet Balder, our new ally. We talked to Óscar García, founder partner.
-
NewAseBio and Alira Health announce Market Access Mentoring Program for 2024
The 2024 program application will open on January 25th and close on February 21st.
-
Press release
AseBio and Alira Health announce Market Access Mentoring Program for 2024
The 2024 program application will open on January 25th and close on February 21st. The 2024 edition format includes a 40-hour service package for three companies that includes an initial meeting
-
